Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Psyence Group Inc C.PSYG

Alternate Symbol(s):  PSYGF

Healthcare Drug Manufacturers - Major Psychedelics
Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, cultivation, and production of psilocybin mushrooms and functional over-the-counter mushroom products. The company offers its functional mushroom products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.


CSE:PSYG - Post by User

Psyence Group Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
  • skydiver069X
Comment by skydiver069on Jun 21, 2022 4:54pm
271 Views
Post# 34772339

RE:Commencement of Online Sales and Distribution of “GOODMIND”

RE:Commencement of Online Sales and Distribution of “GOODMIND” So, the company continues indepth testing in Africa for another couple of months, then releases for Western online sales if medical complaints do not exceed expected values.  Correct?

“We are delighted that our first nutraceutical product, GOODMIND™, is now available for sale online in South Africa."

https://foragoodmind.com/

Either way, after reviewing the website, some of the varieties have caught my attention and thus I would consider testing them out.  As many of us will desire, hopefully there would be no chemical collisions with pharmaceutical medicines.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities